Some blood pressure medications can make the skin extra prone to sunburn. A registry study from Lund University in Sweden shows a possible increased risk of basal cell carcinoma with certain blood pressure medications. The risk increase is relatively low—at most nine percent. “Blood pressure treatment should not be discontinued. But it’s good if doctors inform patients that extra sun protection may be needed,” says researcher Johan Kappelin.

A new study published in Life Metabolism reports that a single post-meal blood biomarker, 1-hour postprandial SPARC (SPARC-1H), can predict who will benefit most from adopting a Mediterranean diet. The discovery provides one of the clearest examples to date of how precision nutrition can identify individualized dietary responses using a simple blood test rather than complex multi-omics models.

One year after announcing a groundbreaking affiliation agreement, Shriners Hospitals for Children Canada and Children’s Hospital at London Health Sciences Centre (LHSC) are proud to announce a joint, pan-Canadian research initiative targeting rare childhood bone disorders.

In August of 2024, the two institutions announced a groundbreaking five-year funding investment through collaboration with Shriners Children’s and Children’s Health Foundation. Following a competitive internal grant competition, the grant will support the Skeletal Tracking to Accelerate Research (STAR) Program, which is an ambitious effort to uncover the mechanisms behind rare bone diseases and to improve care for children across Canada. The STAR Program will be supported by a $400,000 joint research grant to be funded over two years.